Pea Antonio, Tanno Lulu, Nykänen Taina, Prasad Pooja, Tunçer Ceren, Robinson Stuart, Marchegiani Giovanni
Department of Surgery, Istituto Pancreas, Ospedale Universitario Integrato Verona, Verona, Italy.
Department of General Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
Front Med (Lausanne). 2020 Sep 10;7:559. doi: 10.3389/fmed.2020.00559. eCollection 2020.
Pancreatic neuroendocrine tumors (PanNETs) are rare tumors but incidence is increasing. An increasing number of these tumors are diagnosed incidentally when they are small (<2 cm) and when patients are asymptomatic. The European Neuroendocrine Tumor Society (ENETS) recommends conservative watch and wait policy for these patients. However, best surgical approach (parenchyma-sparing or formal oncological resection) for these small tumors when surgery is indicated is currently unknown. Parenchyma-sparing resections such as enucleation is associated with higher risk of post-operative morbidity compared to formal oncological resections. They are also be associated with potentially inadequate surgical margin clearance and with lack of lymphadenectomy for full pathological staging. This study is a retrospective study and the aim is to analyze pre-operative clinical predictors of nodal metastases for small PanNETs to identify which patients are at a lower risk of lymph node metastases and are therefore suitable for parenchyma-sparing resection. The primary endpoint of this study is to determine if pre-operative clinical predictors such as tumor size are associated with lymph node involvement in small PanNETs.
胰腺神经内分泌肿瘤(PanNETs)是罕见肿瘤,但发病率正在上升。越来越多的此类肿瘤在体积较小(<2厘米)且患者无症状时被偶然诊断出来。欧洲神经内分泌肿瘤学会(ENETS)建议对这些患者采取保守的观察等待策略。然而,对于这些需要手术治疗的小肿瘤,目前尚不清楚最佳的手术方式(保留实质或正规肿瘤切除)是什么。与正规肿瘤切除相比,诸如剜除术等保留实质的切除术术后并发症风险更高。它们还可能与手术切缘清除不充分以及缺乏用于全面病理分期的淋巴结清扫有关。本研究是一项回顾性研究,目的是分析小PanNETs淋巴结转移的术前临床预测因素,以确定哪些患者发生淋巴结转移的风险较低,因此适合保留实质的切除术。本研究的主要终点是确定肿瘤大小等术前临床预测因素是否与小PanNETs的淋巴结受累有关。